- Home
- WATT vs BOLT Comparison
WATT vs BOLT Comparison
Compare WATT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- BOLT
- Stock Information
- Founded
- WATT 2012
- BOLT 2015
- Country
- WATT United States
- BOLT United States
- Employees
- WATT N/A
- BOLT N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- BOLT Health Care
- Exchange
- WATT Nasdaq
- BOLT Nasdaq
- Market Cap
- WATT 9.3M
- BOLT 9.4M
- IPO Year
- WATT 2014
- BOLT 2021
- Fundamental
- Price
- WATT $7.45
- BOLT $5.13
- Analyst Decision
- WATT
- BOLT Buy
- Analyst Count
- WATT 0
- BOLT 3
- Target Price
- WATT N/A
- BOLT $47.50
- AVG Volume (30 Days)
- WATT 53.8K
- BOLT 13.8K
- Earning Date
- WATT 07-29-2025
- BOLT 08-14-2025
- Dividend Yield
- WATT N/A
- BOLT N/A
- EPS Growth
- WATT N/A
- BOLT N/A
- EPS
- WATT N/A
- BOLT N/A
- Revenue
- WATT $1,976,000.00
- BOLT $4,167,000.00
- Revenue This Year
- WATT $1,028.91
- BOLT N/A
- Revenue Next Year
- WATT $117.65
- BOLT N/A
- P/E Ratio
- WATT N/A
- BOLT N/A
- Revenue Growth
- WATT 434.05
- BOLT N/A
- 52 Week Low
- WATT $3.67
- BOLT $4.59
- 52 Week High
- WATT $81.00
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- WATT 39.85
- BOLT 41.59
- Support Level
- WATT $7.04
- BOLT $4.98
- Resistance Level
- WATT $8.41
- BOLT $5.44
- Average True Range (ATR)
- WATT 0.71
- BOLT 0.30
- MACD
- WATT 0.03
- BOLT 0.02
- Stochastic Oscillator
- WATT 70.41
- BOLT 38.93
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.